VITASPRING BIOMEDICAL CO., LTD. Income (Loss) from Equity Method Investments
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Income (Loss) from Equity Method Investments of $235.66 thousand for the 3-month period ending 2021-04-30, per its 10-Q filed 2021-06-14.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2021-06-14
- VITASPRING BIOMEDICAL CO., LTD. income (loss) from equity method investments for the quarter ending 2021-04-30 was $235.66K.
- VITASPRING BIOMEDICAL CO., LTD. income (loss) from equity method investments for the quarter ending 2020-04-30 was -$17.75K.
- VITASPRING BIOMEDICAL CO., LTD. income (loss) from equity method investments for fiscal 2021 was -$425.38K, a 6248.03% decline from fiscal 2020.
- VITASPRING BIOMEDICAL CO., LTD. income (loss) from equity method investments for fiscal 2020 was $6.92K.
- VITASPRING BIOMEDICAL CO., LTD. income (loss) from equity method investments for fiscal 2019 was -$22.40K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|
| 2021-04-30 | $235.66K 10-Q · filed 2021-06-14 | |
| 2021-01-31 | -$425.38K 10-K · filed 2021-04-14 | |
| 2020-04-30 | -$17.75K 10-Q · filed 2021-06-14 | |
| 2020-01-31 | $6.92K 10-K · filed 2020-06-09 | |
| 2019-01-31 | -$22.40K 10-K · filed 2020-06-09 |